HIGHLIGHTS
- who: . and collaborators from the Democritus University of Thrace, Greece have published the research work: Adherence and treatment patterns of disease-speci fi c drugs among patients with pulmonary arterial hypertension: A nationwide, new-user cohort study, in the Journal: (JOURNAL) of 31/Dec/2020
- what: This study investigated the second regimen for those who had treatment modifications during the one-year follow-up period and reported 307 (16.2%) patients changed their initial treatment. This trial demonstrated that the combination of ambrisentan and tadalafil significantly reduced the time to composite clinical failure compared with . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.